The Second People's Hospital of GuangDong Province Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2000
NCT01717729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Second People's Hospital of GuangDong Province

Active Ingredients

Drugs in Phase 3 Trials (1)

iodine (1 trial)

Drugs in Phase 2 Trials (1)

autologous mesenchymal stem cells (1 trial)

Drugs in Other Trials (1)

methotrexate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Anemia, Aplastic (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3